PTK2 and breast cancer: Here, we have used the novel and highly specific small-molecule FAK-I BI 85352024 to repress FAK activity in cultured breast cancer cells in vitro and in various preclinical mouse models of breast cancer (Py2T, 4T1, MTflECad/MTΔECad, and MMTV-PyMT) in vivo.